Ovarian Cancer
Molecular signature involving FGF2 characterized in advanced disease
Published in Cancer Weekly, January 4th, 2005
"Epithelial ovarian cancer (EOC) is the gynecological disease with the highest death rate. We applied an automatic class discovery procedure based on gene expression profiling to stages III-IV tumors to search for molecular signatures associated with the biological properties and progression of EOC," reported L. Dececco and colleagues, Istituo Nazionale Tumori, Milan.
"Using a complementary DNA microarray containing 4,451 cancer-related, sequence-verified features, we identified a subset of EOC characterized by the expression of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-01-04)
More Articles from Cancer Weekly
- Breast Cancer
Circulating tumor cells detected in long-term cancer survivors - Cancer Therapy
Resveratrol uses a multi-step process to prevent and fight cancer - Cervical Cancer
Vaccine prevents and treats cervical cancer tumors in mice - Gastroenterology
Lymphatic vessel density and VEGF-C levels shadow pancreatic cancer growth - Prodrug
Flt3 ligand augments suicide gene therapy in a murine colon cancer model - Acute Myeloid Leukemia
Acute myeloid leukemia drug available in Japan after Nippon Shinyaku launch - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
